STOCK TITAN

TrueBlue (TBI) director Sonita Lontoh sells 2,186 common shares in open market

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

TrueBlue, Inc. director Sonita Lontoh reported an open-market sale of 2,186 shares of common stock on June 5, 2026 at a weighted average price of $6.73 per share. After this transaction, she directly holds 72,733 shares. The sale was executed in multiple trades between $6.72 and $6.74 per share.

Positive

  • None.

Negative

  • None.

Insights

Director executed a small open-market sale, retaining a sizeable remaining stake.

Director Sonita Lontoh sold 2,186 shares of TrueBlue, Inc. common stock in an open-market transaction at a weighted average price of $6.73 per share. The trades were broken into multiple executions between $6.72 and $6.74.

Following the sale, she directly holds 72,733 shares, so the transaction represents a small portion of her reported holdings. The filing characterizes this as a standard sale in the open market, with no derivative exercises or tax-withholding events disclosed in this report.

Insider Lontoh Sonita
Role null
Sold 2,186 shs ($15K)
Type Security Shares Price Value
Sale Common Stock 2,186 $6.73 $15K
Holdings After Transaction: Common Stock — 72,733 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 2,186 shares Open-market sale of common stock on June 5, 2026
Weighted average sale price $6.73 per share Average price for 2,186 shares sold
Post-transaction holdings 72,733 shares Common stock directly held after the sale
Price range of trades $6.72–$6.74 per share Range for multiple executions reported in footnote
Net shares sold 2,186 shares Net-sell direction in transaction summary
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
non-derivative financial
"transaction_type: "non-derivative""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lontoh Sonita

(Last)(First)(Middle)
1015 A STREET

(Street)
TACOMA WASHINGTON 98402

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TrueBlue, Inc. [ TBI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026S2,186(1)D$6.7372,733D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $6.72 to $6.74. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, the detailed information regarding the number of shares sold at each separate price.
Remarks:
/s/ Todd N. Gilman, Attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did TrueBlue (TBI) director Sonita Lontoh report?

Director Sonita Lontoh reported selling 2,186 shares of TrueBlue common stock in an open-market transaction. The sale occurred on June 5, 2026, and is classified as a non-derivative transaction in the company’s common stock on this Form 4 filing.

At what price did Sonita Lontoh sell TrueBlue (TBI) shares?

She sold the shares at a weighted average price of $6.73 per share. The trades were executed in multiple transactions, with individual prices ranging from $6.72 to $6.74, according to the detailed pricing footnote included in the Form 4.

How many TrueBlue (TBI) shares does Sonita Lontoh hold after this sale?

After the reported sale, Sonita Lontoh directly holds 72,733 shares of TrueBlue common stock. This indicates that the 2,186 shares sold on June 5, 2026, represent a relatively small fraction of her reported direct holdings in the company.

Was the TrueBlue (TBI) insider trade a buy or sell transaction?

The Form 4 reports a sell transaction by director Sonita Lontoh. It is coded as an open-market sale of common stock, with no corresponding purchase, option exercise, or other acquisition transaction disclosed in this particular insider filing.

Does the TrueBlue (TBI) Form 4 mention derivative or option exercises?

This Form 4 does not report any derivative or option exercises. The transaction involves only non-derivative common stock, classified as an open-market sale, and the derivativeSummary section in the filing is empty for this reporting period.